Protagenic Therapeutics (PTIX) News Today $0.67 +0.11 (+19.43%) (As of 09:34 AM ET) Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsFinancialsInsider TradesSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Protagenic Therapeutics faces Nasdaq delisting over equity deficitDecember 5, 2024 | investing.comProtagenic Therapeutics, Inc.: Protagenic Therapeutics Announces Closing of Private Placement for Aggregate Gross Proceeds of $1.275 MillionNovember 5, 2024 | finanznachrichten.deProtagenic Therapeutics' Stress-Regulating Peptide Demonstrates Exceptional Safety in Single Dose Portion of Phase I Trial, Paving the Way for Next Steps Toward Potential Breakthrough Treatments in Stress Related Neuropsychiatric DisordersMay 22, 2024 | finance.yahoo.comProtagenic Therapeutics, Inc.: Protagenic Therapeutics' Innovative Peptide PT00114 to be Highlighted at Boston SummitApril 17, 2024 | finanznachrichten.deProtagenic Therapeutics’ Innovative Peptide PT00114 to be Highlighted at Boston SummitApril 17, 2024 | finance.yahoo.comProtagenic Therapeutics, Inc. (NASDAQ:PTIX) Q4 2023 Earnings Call TranscriptApril 2, 2024 | msn.comProtagenic Therapeutics Successfully Concludes Third Cohort in Single Dose Portion of Phase 1 Trial for Stress-Related Neuropsychiatric DisordersMarch 27, 2024 | finance.yahoo.comProtagenic Therapeutics, Inc.: Protagenic Therapeutics Schedules First Q4 and FY 2023 Earnings CallMarch 25, 2024 | finanznachrichten.deProtagenic Therapeutics Achieves First Clinical Safety Milestone with its Novel Neuropeptide for the Potential Treatment of Stress-Related DisordersFebruary 13, 2024 | finance.yahoo.comTrading was temporarily halted for "PTIX" at 02:01 PM with a stated reason of "LULD pause."January 4, 2024 | marketbeat.comProtagenic Therapeutics Inc PTIXDecember 17, 2023 | morningstar.comPTIX Protagenic Therapeutics, Inc.November 14, 2023 | seekingalpha.comProtagenic Therapeutics, Inc.: Protagenic Therapeutics Announces Date of Annual Shareholder MeetingOctober 13, 2023 | finanznachrichten.deProtagenic Therapeutics Announces Date of Annual Shareholder MeetingOctober 13, 2023 | finance.yahoo.comProtagenic Therapeutics, Inc.: Protagenic Therapeutics Initiates Phase I/IIa Clinical Trial for Groundbreaking Brain Peptide PT00114September 26, 2023 | finanznachrichten.deProtagenic Therapeutics Initiates Phase I/IIa Clinical Trial for Groundbreaking Brain Peptide PT00114September 26, 2023 | finance.yahoo.comPTIX - Protagenic Therapeutics, Inc.June 17, 2023 | uk.finance.yahoo.comProtagenic Therapeutics Stock (NASDAQ:PTIX), DividendsMarch 24, 2023 | benzinga.comProtagenic Therapeutics, Inc.: Protagenic Therapeutics to Effect 1-for-4 Reverse Stock SplitMarch 22, 2023 | finanznachrichten.deProtagenic Therapeutics to Effect 1-for-4 Reverse Stock SplitMarch 22, 2023 | finance.yahoo.comPTIX_old Historical DataSeptember 7, 2022 | investing.comProtagenic Therapeutics, Inc. (PTIX)August 12, 2022 | finance.yahoo.comProtagenic Therapeutics to Present at the B. Riley Securities Neuro and Ophthalmology Virtual Investor Conference on April 27thApril 26, 2022 | finance.yahoo.comProtagenic Therapeutics, Inc. Common Stock (PTIX)January 20, 2022 | nasdaq.comProtagenic Therapeutics Announces Third Quarter 2021 Results and Business UpdateNovember 16, 2021 | finance.yahoo.comProtagenic Therapeutics to Host Virtual Science Review Wednesday, September 8th at 10 AM ETAugust 30, 2021 | finance.yahoo.comProtagenic Therapeutics Announces Second Quarter 2021 Results and Provides Business UpdateAugust 17, 2021 | finance.yahoo.comProtagenic Therapeutics Updates on Patient Enrollment for PT00114 Trial, Shares LowerJuly 23, 2021 | marketwatch.comProtagenic Therapeutics Updates Timeline for Commencement of Patient Enrollment for PT00114 ...July 23, 2021 | apnews.comProtagenic Therapeutics Updates Timeline for Commencement of Patient Enrollment for PT00114 Clinical TrialJuly 23, 2021 | finance.yahoo.com Get Protagenic Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for PTIX and its competitors with MarketBeat's FREE daily newsletter. Email Address Has Trump Finally Gone Too Far? (Ad)Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news. Register For The Webinar To Discover PTIX Media Mentions By Week PTIX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PTIX News Sentiment▼1.440.65▲Average Medical News Sentiment PTIX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PTIX Articles This Week▼10▲PTIX Articles Average Week Get Protagenic Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for PTIX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Relmada Therapeutics News NRx Pharmaceuticals News AIM ImmunoTech News Talphera News Imunon News Kazia Therapeutics News ImmunoPrecise Antibodies News Aspira Women's Health News Jaguar Health News Sensei Biotherapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PTIX) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | Sponsored2025’s #1 Trump TradeAll the Energy You Need to Power Your Entire Life... Could Fit Inside This Single Soda Can. Three Companies...The Oxford Club | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored50-year Wall Street legend: “Sell this tech stock NOW”Something very strange is happening to U.S. stocks following President Trump's victory... And this could s...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Protagenic Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Protagenic Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PTIX Stock Alerts